Skip to main content

Advertisement

Log in

Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

A Commentary to this article was published on 05 September 2020

Abstract

Introduction and hypothesis

To analyze the reasons for eventual choice of a therapeutic intervention in subjects who initially chose observation for bothersome pelvic organ prolapse (POP) over therapeutic intervention at their first urogynecology clinic visit.

Methods

This is a retrospective cohort study of women with bothersome POP who initially chose observation over therapeutic intervention at one institution from 2002 to 2015. Subjects were followed over time with sequential pelvic organ prolapse quantification examinations (POP-Q) and assessments of symptoms and bother utilizing non-validated standard questions. Subjects were divided into two groups: (1) those who chose continued observation versus (2) those who chose therapeutic intervention with either pessary or surgery. Demographic information, POP-Q examinations, and POP symptoms and bother were collected. We analyzed which clinical variables influenced patient decision to elect for therapeutic intervention.

Results

A total of 111 subjects were enrolled. The distribution of initial POP-Q stage was: stage 2 = 54%; stage 3 = 45%; stage 4 = 1%. Median follow-up was 24 months (range 6 and 110 months). At their last recorded visit, 73 subjects (66%) continued observation and 38 subjects (34%) chose pessary or surgical intervention. We investigated clinical factors for choosing intervention. Increase in POP symptom bother was the only variable that remained significant in determining patient choice of a therapeutic intervention (p < 0.001) after confounding factors were controlled for using multivariate regression analysis.

Conclusion

In subjects with bothersome POP who initially choose observation and subsequently elect to pursue a therapeutic intervention, worsening symptom bother is the most important factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2.
Fig. 3

Similar content being viewed by others

References

  1. Wu JM, Matthews CA, Conover MM, et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201–6. https://doi.org/10.1097/AOG.0000000000000286.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sung VW, Hampton BS. Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin N Am. 2009;36(3):421–43. https://doi.org/10.1016/j.ogc.2009.08.002.

    Article  Google Scholar 

  3. Wu JM, Hundley AF, Fulton RG, et al. Forecasting the prevalence of pelvic floor disorders in US women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83. https://doi.org/10.1097/AOG.0b013e3181c2ce96.

    Article  PubMed  Google Scholar 

  4. Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6. https://doi.org/10.1016/S0029-7844(97)00058-6.

    Article  CAS  PubMed  Google Scholar 

  5. Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94. https://doi.org/10.1007/s00192-015-2932-1.

    Article  PubMed  Google Scholar 

  6. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369(9566):1027–38. https://doi.org/10.1016/S0140-6736(07)60462-0.

    Article  PubMed  Google Scholar 

  7. Gilchrist AS, Campbell W, Steele H, et al. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32(4):383–6. https://doi.org/10.1002/nau.22298.

    Article  PubMed  Google Scholar 

  8. Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213. https://doi.org/10.1007/s00192-016-3123-4.

    Article  PubMed  Google Scholar 

  9. Handa VL, Garrett E, Hendrix S, et al. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190(1):27–32. https://doi.org/10.1016/j.ajog.2003.07.017.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

M Mbaye: Data collection, Data analysis, Manuscript writing.

A Edenfield: Study development, Data collection, Data analysis, Manuscript writing. A Woll: Data collection, Data analysis.

S Swift: Study development, Data collection, Data analysis, Manuscript editing.

Corresponding author

Correspondence to Steven E. Swift.

Ethics declarations

Conflict of interest

None for M Mbaye, A Edenfield and A Woll. S Swift is a local researcher for PI Cook Myosite.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mbaye, M., Autumn Edenfield, L., Woll, A. et al. Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse. Int Urogynecol J 32, 273–278 (2021). https://doi.org/10.1007/s00192-020-04466-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-020-04466-3

Keywords

Navigation